Research and Markets - Lack of Genuine Innovation and Lack of Commitment to Refining Existing R&D Processes Continue to Inhibit Growth in Pharmaceutical Industry

Research and Markets (researchandmarkets.com/reports/c9310) has announced the addition of Winning Pharmaceutical R&D Strategies: Boosting profitability through improvements in portfolio management, licensing and clinical trials to their offering.

(PRWEB) November 17, 2004 -- Research and Markets (http://www.researchandmarkets.com/reports/c9310) has announced the addition of Winning Pharmaceutical R&D Strategies: Boosting profitability through improvements in portfolio management, licensing and clinical trials to their offering.

Conflict between the continued need to meet investors' short-term growth expectations and longer term productivity problems has led to a substantial increase in R&D expenditure in a bid to maintain profit margins. However, pharmaceutical companies are experiencing diminishing returns on investment in their R&D pipelines. Factors greatly inhibiting the industry are the lack of genuine innovation and the lack of commitment to refining existing R&D processes with a view to generating greater efficiencies and substantial cost savings. Improving the productivity of each step of the R&D process can improve margins without related expansion of the R&D budget. Long-term, this is a more sustainable growth strategy than continued investment in current activities. This title examines the core areas where companies can implement procedural enhancements to maximize their resources and eliminate inefficiencies in the R&D process and as a result generate greater returns on investment.

Contents Include:
- Pharmas R&D challenge
- Portfolio management to optimize resource allocation
- Filling portfolio gaps as the licensing partner of choice
- Improving trial design to reduce time to market

Case Studies include:
Pre-approval comparator studies: AstraZenecas Exanta and GlaxoSmithKlines Lexiva
Post-approval comparator study: Merck & Co.s Vasotec

For more information visit http://www.researchandmarkets.com/reports/c9310

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980

###